pyrroles has been researched along with azomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, KC; Mroczkowski, Z; Rupp, WD | 1 |
| Rockwell, S | 1 |
| Chin, JB; Rauth, AM; Sheinin, DM | 1 |
| Bryan, GT; Muraoka, K; Wang, CY | 1 |
| Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
| Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Jung, SM; Lee, CC; Tsai, CS; Wang, CC; Wen, CJ | 1 |
| Bali, S; Bhutta, MF; Brown, SD; Cheeseman, MT; Hilton, H; Hough, TA; Parker, A; Pathak, P; Potter, PK; Purnell, T; Romero, MR; Tyrer, HE; Vizor, L; Vowell, K; Wells, S; Williams, D | 1 |
| Balfour, MN; Franco, CH; Freitas-Junior, LH; Moraes, CB; Stefani, HA | 1 |
1 review(s) available for pyrroles and azomycin
| Article | Year |
|---|---|
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |
7 other study(ies) available for pyrroles and azomycin
| Article | Year |
|---|---|
Hypoxic radiosensitizers: prospects for effective compounds with fewer toxic side-effects.
Topics: beta-Galactosidase; Escherichia coli; Mutation; Nitroimidazoles; Pyrroles; Radiation-Sensitizing Agents | 1978 |
Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Topics: Animals; Cell Survival; In Vitro Techniques; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxygen; Pyrroles; Radiation-Sensitizing Agents; Thiazoles | 1978 |
Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.
Topics: Drug Evaluation, Preclinical; Genetic Techniques; Mutagens; Nitro Compounds; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Pyrroles; Radiation-Sensitizing Agents; Salmonella typhimurium | 1978 |
Mutagenicity of nitrofurans, nitrothiophenes, nitropyrroles, nitroimidazole, aminothiophenes, and aminothiazoles in Salmonella typhimurium.
Topics: Amines; DNA Repair; DNA, Bacterial; Heterocyclic Compounds; Mutagens; Nitro Compounds; Nitrofurans; Nitroimidazoles; Pyrroles; Salmonella typhimurium; Structure-Activity Relationship; Thiazoles; Thiophenes | 1975 |
Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Aggregation; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Drug Resistance, Neoplasm; Endothelial Cells; Green Fluorescent Proteins; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Nitroimidazoles; Prostatic Neoplasms; Pyrroles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Salvage Therapy; Sunitinib; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2011 |
HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.
Topics: Animals; Blister; Body Fluids; Cell Hypoxia; Disease Models, Animal; Ear, Middle; Gene Expression Regulation; Hearing Loss; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Nitroimidazoles; Otitis Media with Effusion; Phthalazines; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sunitinib; Vascular Endothelial Growth Factor A | 2011 |
Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Topics: Animals; Cells, Cultured; Chagas Disease; Humans; Models, Molecular; Molecular Structure; Nitroimidazoles; Parasitic Sensitivity Tests; Pyridines; Pyrroles; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2017 |